Following general knowledge and current affairs sharpens awareness, improves analytical thinking, and enhances confidence.
Staying updated with general knowledge and current affairs empowers aspirants to think critically and act wisely. Daily ...
Current Affairs play a vital role in all competitive exams, especially in UPSC, SSC, Banking, and State PCS. Staying updated with daily events, government schemes, and global developments is key to ...
Current Affairs One Liners 06 Oct 2025: For students preparing for competitive exams and aware readers, Jagran Josh presents today’s one-liner Current Affairs. This section covers key topics like the ...
The Department of Examinations has announced that the closing date for online applications for the 2025 GCE Ordinary Level Examination is 9th October 2025 at midnight. Applications have been open ...
Current Affairs Quiz 01 Oct 2025: For students preparing for competitive exams and aware readers, Jagran Josh brings this week’s important Current Affairs Quiz. This quiz includes questions related to ...
The Election Commission of India (ECI) published the final electoral list for Bihar, comprising 74.2 million voters, roughly 4.7 million names lighter than at the beginning of the controversial ...
Police in North West have welcomed the sentencing of 40-year-old Lesotho national, Elias Tsetla, who received two life terms for raping his girlfriend. The Potchefstroom Regional Court handed down the ...
Lorde’s highly anticipated fourth album, Virgin, is finally here to soundtrack our summer. Along with praise from critics and longtime fans, the Grammy winner’s latest record has faced some backlash ...
We have all the winners for the 46th annual News & Documentary Emmy Awards. The News categories were in the spotlight Wednesday at the Palladium Times Square in New York City, which also is set to ...
National health expenditures are projected to have grown 8.2 percent in 2024 and to increase 7.1 percent in 2025, reflecting continued strong growth in the use of health care services and goods.
Oral Paxlovid (nirmatrelvir-ritonavir) is highly effective at preventing hospitalization and death from COVID-19, yet it has been remarkably underused, even by patients at highest risk from COVID-19, ...